Cargando…
DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation
DNMT3A mutations play a prominent role in clonal hematopoiesis and myeloid neoplasms with arginine (R)882 as a hotspot, however the clinical implications of R882 vs. non-R882 mutations in myeloid neoplasms like myelodysplastic syndrome (MDS) is unclear. By data mining with publicly accessible cancer...
Autores principales: | Jawad, Majd, Afkhami, Michelle, Ding, Yi, Zhang, Xiaohui, Li, Peng, Young, Kim, Xu, Mina Luqing, Cui, Wei, Zhao, Yiqing, Halene, Stephanie, Al-Kali, Aref, Viswanatha, David, Chen, Dong, He, Rong, Zheng, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918526/ https://www.ncbi.nlm.nih.gov/pubmed/35296003 http://dx.doi.org/10.3389/fonc.2022.849376 |
Ejemplares similares
-
DNMT3A(R882)-associated hypomethylation patterns are maintained in primary AML xenografts, but not in the DNMT3A(R882C) OCI-AML3 leukemia cell line
por: Chen, David, et al.
Publicado: (2018) -
Influence of DNMT3A R882 mutations on AML prognosis determined by the allele ratio in Chinese patients
por: Yuan, Xiao-Qing, et al.
Publicado: (2019) -
Clinical Features and MicroRNA Expression Patterns Between AML Patients With DNMT3A R882 and Frameshift Mutations
por: Yang, Li, et al.
Publicado: (2019) -
The DNMT3A R882H mutation does not cause dominant negative effects in purified mixed DNMT3A/R882H complexes
por: Emperle, Max, et al.
Publicado: (2018) -
DNMT3A R882 Mutations Predict a Poor Prognosis in AML: A Meta-Analysis From 4474 Patients
por: Yuan, Xiao-Qing, et al.
Publicado: (2016)